Journal of Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

1小时前 ms3000000526424880 来自四川省

前往app查看评论内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2024-08-02 120592f7m52(暂无昵称) 来自山东省

Journal of Translational Medicine已经投稿一周了，都是new submission的状态

6 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2024-07-17 lxx9853120 来自河南省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：2024-03-25 投稿 submited
2024-03-29 分配编辑 editor assigned
2024-04-02 邀请审稿人 reviewers invited
2024-04-05 同意审稿 reviewers agreed
2024-04-29 审稿 (一审) under review
2024-05-30 小修 minor revised
2024-06-03 审稿 (二审) under review
2024-06-11 接收 accepted
文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。

15 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2024-04-03 ms8000000910900972 来自广东省

偏重的研究方向：肿瘤
经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review

93 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2024-05-14 ms8000001755451924 来自北京

偏重的研究方向：风湿免疫
经验分享：5.5 Submit.
5.7 Editor Assigned.
5.8 Reviewers Assigned.
5.10 Reviewers Assigned.
到现在也没变化了。坐等着急死

37 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2024-07-30 ms4000001924876552 来自四川省

这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了

12 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2024-07-12 ms7000001553626851 来自湖南省

5-8 Submission
5-11 Editor Assigned
6-7 Review Assigned
6-19 Review Assigned(日期变动)
目前还是Review assigned
找审稿人太慢了

37 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2023-11-26 1240adaem89暂无昵称来自四川省

这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned

163 30

展开30条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2023-10-07 Easyreal 来自安徽省

偏重的研究方向：肿瘤;临床
经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！

111 31

展开31条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218842, encodeId=b1ab221884219, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a28840735, createdName=ms3000000526424880, createdTime=Tue Aug 06 19:44:10 CST 2024, time=1小时前, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2218107, encodeId=041f221810ef5, content=Journal of Translational Medicine已经投稿一周了，都是new submission的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/17/df8b1f0fed98aba4ebc2c4e1bd0c9093.jpg, createdBy=813a2173568, createdName=120592f7m52(暂无昵称), createdTime=Fri Aug 02 13:07:39 CST 2024, time=2024-08-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2215515, encodeId=1cca22155159d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2024-03-25 投稿 submited 2024-03-29 分配编辑 editor assigned 2024-04-02 邀请审稿人 reviewers invited 2024-04-05 同意审稿 reviewers agreed 2024-04-29 审稿 (一审) under review 2024-05-30 小修 minor revised 2024-06-03 审稿 (二审) under review 2024-06-11 接收 accepted 文章接收后，移交出版社，见刊时间长。期间可以询问编辑进展，编辑很快与出版社同事对接，处理问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7712649720, createdName=lxx9853120, createdTime=Wed Jul 17 23:39:51 CST 2024, time=2024-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204557, encodeId=57c0220455e6b, content=偏重的研究方向：风湿免疫 经验分享：5.5 Submit. 5.7 Editor Assigned. 5.8 Reviewers Assigned. 5.10 Reviewers Assigned. 到现在也没变化了。坐等着急死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9299667, createdName=ms8000001755451924, createdTime=Tue May 14 01:43:01 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217610, encodeId=c0ad221e6104e, content=这个杂志如果editor assigned时间非常长的是不是到最后都被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c019141310, createdName=ms4000001924876552, createdTime=Tue Jul 30 15:52:52 CST 2024, time=2024-07-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214550, encodeId=84802214550b2, content=5-8 Submission 5-11 Editor Assigned 6-7 Review Assigned 6-19 Review Assigned(日期变动) 目前还是Review assigned 找审稿人太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5cf8831010, createdName=ms7000001553626851, createdTime=Fri Jul 12 08:52:49 CST 2024, time=2024-07-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2171025, encodeId=062b21e10253e, content=这个杂志官网号称第一次决定5天，到现在18天了还在editor assigned，然后在这周一发了催稿邮件，一直没有回复，大家一般发了催稿邮件多久收到回复？然后这个杂志撤稿的话是也是直接在系统里发邮件吗？附上自己的投稿周期 11.8号，new submission 11.10号，editor assigned 11.11号，editor assigned 11.21号，发催稿邮件至今没回复 11.26号，依旧是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sun Nov 26 09:41:09 CST 2023, time=2023-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161275, encodeId=da9b21612e57c, content=偏重的研究方向：肿瘤;临床 经验分享：6月27号submit 过了9天（7月6号）没过初审，它们期刊号称第一次决定不超过8天，果断催了一下。当天分配编辑。 7月8号reviewer assigned 7月10号under review 8月10号还是under review，再次发邮件催，客套回复。 8月18号reviews completed ，当天收到修稿意见（major revision）给的大修感觉像是小修，给了1个月。 9月10号返修，9月11号under review，一直等到10月5号（其实是放假没管），今天早上起来一看accept。还行，感觉编辑挺好的，每次催虽然官话回复但也都采取行动了。祝大家都能accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67e18760865, createdName=Easyreal, createdTime=Sat Oct 07 08:02:21 CST 2023, time=2023-10-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215931, encodeId=29a02215931e4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：24-5-6投稿，一周左右分配编辑，很快就under review 24-6-8审稿意见，major revised 24-7-1修回 24-7-17接收，accepted 整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c041613072, createdName=xinxilan, createdTime=Sat Jul 20 19:36:40 CST 2024, time=2024-07-20, status=1, ipAttribution=江苏省)]

2024-07-20 xinxilan 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：24-5-6投稿，一周左右分配编辑，很快就under review
24-6-8审稿意见，major revised
24-7-1修回
24-7-17接收，accepted
整个过程还是比较顺利。编辑也很给力，希望大家都好运哦。

15 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务